Back

Choose your region

Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
6201 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 68
6202 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 63
6203 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 57
6204 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 68
6205 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 56
6206 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 61
6207 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 55
6208 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 64
6209 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 64
6210 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 52
6211 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 55
6212 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 67
6213 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 49
6214 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 56
6215 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 47
6216 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 53
6217 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 58
6218 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 49
6219 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 69
6220 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 61
6221 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 54
6222 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 65
6223 Apheresis Autologous Multiple Myeloma Hematology 2016 Standard Therapy Germany 48
6224 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 60
6225 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 56
6226 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 50
6227 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 73
6228 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 47
6229 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 67
6230 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 62
6231 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 61
6232 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 68
6233 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 65
6234 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 15
6235 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 52
6236 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 20
6237 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 60
6238 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 9
6239 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 61
6240 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 63
6241 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 15
6242 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 37
6243 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 59
6244 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 62
6245 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 58
6246 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 69
6247 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Poland 66
6248 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Germany 67
6249 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2016 Standard Therapy Germany 57
6250 Apheresis Allogeneic Myelodysplastic Syndrome – Rcmd Hematology 2016 Standard Therapy Poland 32
6251 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb Hematology 2016 Standard Therapy Poland 56
6252 Apheresis Allogeneic Myelofibrosis Hematology 2016 Standard Therapy Poland 72
6253 Apheresis Allogeneic Myelofibrosis Hematology 2016 Standard Therapy Poland 66
6254 Apheresis Allogeneic Myelofibrosis Hematology 2016 Standard Therapy Poland 67
6255 Apheresis Allogeneic Myeloma Multiplex Hematology 2016 Standard Therapy Poland 63
6256 Apheresis Allogeneic Myeloma Multiplex Hematology 2016 Standard Therapy Poland 51
6257 Apheresis Allogeneic Myeloma Multiplex Hematology 2016 Standard Therapy Poland 38
6258 Apheresis Allogeneic Myeloproliferative Syndrome Hematology 2016 Standard Therapy Poland 52
6259 Apheresis Allogeneic Myeloproliferative Syndrome Hematology 2016 Standard Therapy Germany 63
6260 Apheresis Autologous Neuroblastoma Hematology 2016 Standard Therapy Germany 5
6261 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 45
6262 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 70
6263 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 43
6264 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 69
6265 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 28
6266 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 1
6267 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 30
6268 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 71
6269 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 58
6270 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 17
6271 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 59
6272 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 58
6273 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 55
6274 Apheresis Allogeneic No Data no data 2016 Standard Therapy Poland 44
6275 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 38
6276 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 58
6277 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 32
6278 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Poland 39
6279 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 61
6280 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 73
6281 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 27
6282 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 65
6283 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2016 Standard Therapy Germany 61
6284 Apheresis Allogeneic Plasma Cell Disorder Hematology 2016 Standard Therapy Poland 47
6285 Apheresis Autologous Plasmacytoma Hematology 2016 Standard Therapy Germany 58
6286 Apheresis Autologous Plasmacytoma Hematology 2016 Standard Therapy Germany 68
6287 Apheresis Autologous Plasmacytoma Hematology 2016 Standard Therapy Germany 48
6288 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2016 Standard Therapy Germany 62
6289 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2016 Standard Therapy Germany 51
6290 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2016 Standard Therapy Germany 62
6291 Apheresis Allogeneic Primary Immunodeficiency Hematology 2016 Standard Therapy Poland 5
6292 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Poland 50
6293 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Poland 67
6294 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Poland 67
6295 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Germany 56
6296 Apheresis Allogeneic Primary Myelofibrosis Hematology 2016 Standard Therapy Germany 58
6297 Apheresis Allogeneic Refractory Anemia With Excess Blasts Hematology 2016 Standard Therapy Poland 62
6298 Apheresis Allogeneic Saa / Amyloidosis Hematology 2016 Standard Therapy Poland 45
6299 Apheresis Allogeneic Secondary Acute Myeloid Leukemia At Myeloproliferative Syndrome Hematology 2016 Standard Therapy Germany 28
6300 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2016 Standard Therapy Poland 18